These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7875420)
1. [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse]. Bado A; Corrion F; Bernades P; Chevalier T; Galmiche JP; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F Gastroenterol Clin Biol; 1994; 18(6-7):623-9. PubMed ID: 7875420 [TBL] [Abstract][Full Text] [Related]
2. [Effect of enprostil on the healing and the recurrence of duodenal ulcer. Comparison with ranitidine]. Lartigue S; Corrion F; Bernades P; Bonfils S; Chevalier T; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F Gastroenterol Clin Biol; 1994; 18(6-7):617-22. PubMed ID: 7875419 [TBL] [Abstract][Full Text] [Related]
3. Gastric ulcer healing: a comparison of enprostil versus ranitidine. Bardhan KD; Walker R; Hinchliffe RF; Bose K; Morris P; Thompson M; Miller JP; Toivanen E; Thompson RP; Patrier P J Clin Gastroenterol; 1991 Apr; 13(2):157-62. PubMed ID: 1903407 [TBL] [Abstract][Full Text] [Related]
4. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. Thomas FJ; Koss MA; Hogan DL; Isenberg JI Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654 [TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma. Sherbaniuk R; Jewell LD; Yacoub W; Pinchbeck B; Salkie ML; Walker K; Mahachai V; Kirdeikis P; Zuk L; Brunet MK Clin Ther; 1986; 8(6):667-88. PubMed ID: 2878726 [TBL] [Abstract][Full Text] [Related]
6. A comparison of enprostil and ranitidine in treatment of duodenal ulcer. Bardhan KD; Lee FI; Bose K; Hinchliffe RF; Morris P; Thompson M; Whittaker L; Hardman M; Maxton DG; Colin R J Clin Gastroenterol; 1988 Apr; 10(2):137-42. PubMed ID: 3138303 [TBL] [Abstract][Full Text] [Related]
8. A comparison of low-dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence. Bardhan KD; Morris P; Hinchliffe RF; Saunders JH; MacDougall BR; Bold JM; Freeman PR Aliment Pharmacol Ther; 1989 Oct; 3(5):489-97. PubMed ID: 2518862 [TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433 [TBL] [Abstract][Full Text] [Related]
10. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease. Mahachai V; Walker K; Sevelius H; Thomson AB Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591 [TBL] [Abstract][Full Text] [Related]
11. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics. Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer. Walt RP; Pounder RE; Hawkey CJ; Santana IA; Somerville KW; Logan RF; Long RG; Langman MJ Aliment Pharmacol Ther; 1987 Apr; 1(2):161-6. PubMed ID: 2979218 [TBL] [Abstract][Full Text] [Related]
13. [Stomach ulcer healing with enprostil, an orally effective prostaglandin E2 analog: direct comparative study with ranitidine]. Hüttemann W; Beckenbach HP; Daake H; Dammann HG; Jancke T; Kalek HD; Kühn V; Martens W; Müller P; Rohner HG Z Gastroenterol; 1986 May; 24(5):252-6. PubMed ID: 3088859 [TBL] [Abstract][Full Text] [Related]
14. Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial. Lauritsen K; Laursen LS; Havelund T; Bytzer P; Svendsen LB; Rask-Madsen J Br Med J (Clin Res Ed); 1986 Mar; 292(6524):864-6. PubMed ID: 3083913 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing. Simon B; Dammann HG; Müller P Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657 [TBL] [Abstract][Full Text] [Related]
16. [The treatment of patients with duodenal peptic ulcer with a synthetic prostaglandin E2 analog (enprostil)]. Loginov AS; Zverkov IV; Kondashova ZD; Sokolova GN; Minushkin ON Ter Arkh; 1992; 64(8):77-9. PubMed ID: 1440404 [No Abstract] [Full Text] [Related]
17. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. Goa KL; Monk JP Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276 [TBL] [Abstract][Full Text] [Related]
18. A comparison between enprostil and ranitidine in the management of gastric ulceration. Morgan AG; Pacsoo C; Taylor P; McAdam WA Aliment Pharmacol Ther; 1990 Dec; 4(6):635-41. PubMed ID: 2129650 [TBL] [Abstract][Full Text] [Related]
19. Enprostil and ranitidine: comparative efficacy and safety in patients with duodenal ulcer. Mackinnon M; Alp M; Austad WI; Byrnes D; Cowen A; Duggan J; Pirola R; Thomas M; Ward M Aust N Z J Med; 1987 Jun; 17(3):316-20. PubMed ID: 3118861 [TBL] [Abstract][Full Text] [Related]
20. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. Lauritsen K; Havelund T; Laursen LS; Bytzer P; Kjaergaard J; Rask-Madsen J Br Med J (Clin Res Ed); 1987 Apr; 294(6577):932-4. PubMed ID: 3107660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]